🇺🇸 FDA
Pipeline program

OPDIVO 10 mg/mL concentrate for solution for infusion., Inrebic 100 mg hard capsules

FRACTION_2021

Phase 2 small_molecule active

Quick answer

OPDIVO 10 mg/mL concentrate for solution for infusion., Inrebic 100 mg hard capsules for Primary and secondary Myelofibrosis is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Primary and secondary Myelofibrosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials